| RS398123387 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS398123388 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS398123389 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS398123390 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS398123391 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Inborn genetic diseases |
| RS398123392 |
NEU1
|
Health Risk |
Pathogenic/Likely pathogenic |
Sialidosis, Sialidosis type 2 |
| RS398123394 |
PDE6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS398123397 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS398123398 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS398123401 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS398123402 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS398123405 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS398123406 |
STK11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS398123408 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 1B, Peroxisome biogenesis disorder 1A (Zellweger) |
| RS398123409 |
PEX1
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 1A (Zellweger), Zellweger spectrum disorders |
| RS398123411 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS398123412 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS398123413 |
ARSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Metachromatic leukodystrophy, ARSA-related disorder |
| RS398123414 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS398123415 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS398123416 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS398123418 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS398123419 |
ARSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS398123420 |
ATRX
|
Health Risk |
Pathogenic/Likely pathogenic |
Alpha-thalassemia/intellectual disability syndrome, Alpha-thalassemia/intellectual disability syndrome |
| RS398123422 |
ATRX
|
Health Risk |
Pathogenic |
— |
| RS398123424 |
ATRX
|
Health Risk |
Pathogenic |
— |
| RS398123425 |
ATRX
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability-hypotonic facies syndrome, X-linked |
| RS398123428 |
ATRX
|
Health Risk |
Pathogenic |
— |
| RS398123429 |
GALNS
|
Health Risk |
Pathogenic |
Morquio syndrome, Mucopolysaccharidosis |
| RS398123430 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS398123431 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS398123432 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS398123434 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS398123435 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS398123437 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS398123438 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS398123439 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS398123440 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS398123441 |
GALNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS398123443 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS398123444 |
HEXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Sandhoff disease, Sandhoff disease |
| RS398123445 |
HEXB
|
Health Risk |
Pathogenic |
— |
| RS398123446 |
HEXB
|
Health Risk |
Pathogenic/Likely pathogenic |
Sandhoff disease, Sandhoff disease |
| RS398123447 |
HEXB
|
Health Risk |
Likely pathogenic |
— |
| RS398123448 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS398123450 |
HEXB
|
Health Risk |
Likely pathogenic |
— |
| RS398123455 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS398123456 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS398123457 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS398123460 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS398123461 |
PCCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, PCCB-related disorder |
| RS398123462 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS398123463 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS398123464 |
PCCB
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS398123466 |
PLP1
|
Health Risk |
Likely pathogenic |
— |
| RS398123467 |
PLP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 2, Pelizaeus-Merzbacher disease |
| RS398123469 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Inborn genetic diseases |
| RS398123470 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398123471 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Centronuclear myopathy |
| RS398123472 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS398123473 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Central core myopathy, Malignant hyperthermia |
| RS398123474 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS398123475 |
SMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type B |
| RS398123476 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS398123478 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS398123479 |
SMPD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type A |
| RS398123481 |
VHL
|
Health Risk |
Pathogenic/Likely pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS398123482 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome |
| RS398123483 |
VHL
|
Health Risk |
Pathogenic/Likely pathogenic |
Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome |
| RS398123486 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398123489 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398123490 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398123491 |
BCKDHA
|
Health Risk |
Pathogenic |
— |
| RS398123492 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398123493 |
BCKDHA
|
Health Risk |
Pathogenic |
— |
| RS398123494 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS398123495 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease |
| RS398123496 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398123497 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398123498 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398123499 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398123503 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398123504 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS398123505 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398123508 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398123509 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398123510 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS398123512 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease type 1A, Maple syrup urine disease type 1A |
| RS398123513 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398123514 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398123515 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398123517 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS398123518 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398123519 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Brugada syndrome 3 |
| RS398123521 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS398123523 |
GABRG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Febrile seizures, familial |
| RS398123525 |
ALG11
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG11-congenital disorder of glycosylation, ALG11-congenital disorder of glycosylation |
| RS398123526 |
GBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gaucher disease, Gaucher disease |
| RS398123527 |
GBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gaucher disease, Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome |
| RS398123528 |
GBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gaucher disease, Gaucher disease type I |